TWO SIGMA INVESTMENTS, LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,032,850
-90.4%
227,000
-85.2%
0.00%
-88.9%
Q2 2023$10,778,613
-31.0%
1,531,053
-40.1%
0.03%
-40.0%
Q1 2023$15,624,413
+173.5%
2,557,187
+186.1%
0.04%
+150.0%
Q4 2022$5,712,232
-57.7%
893,933
-36.7%
0.02%
-60.9%
Q3 2022$13,519,000
+129.5%
1,411,158
+164.5%
0.05%
+142.1%
Q2 2022$5,891,000
+183.2%
533,600
+327.2%
0.02%
+216.7%
Q1 2022$2,080,000
-71.5%
124,900
-67.3%
0.01%
-62.5%
Q4 2021$7,290,000
+14.2%
381,881
+47.5%
0.02%
+14.3%
Q3 2021$6,385,000
+18.4%
258,930
+52.0%
0.01%0.0%
Q1 2021$5,392,000
-62.2%
170,300
-44.6%
0.01%
-65.9%
Q4 2020$14,252,000
+3937.4%
307,162
+2761.0%
0.04%
+4000.0%
Q3 2020$353,000
-85.5%
10,736
-87.9%
0.00%
-91.7%
Q2 2020$2,432,000
-53.6%
88,609
-53.2%
0.01%
-25.0%
Q4 2019$5,241,000
-42.6%
189,327
-62.3%
0.02%
-48.4%
Q3 2019$9,132,000
+540.8%
501,770
+234.9%
0.03%
+520.0%
Q1 2019$1,425,000
-54.2%
149,841
-57.4%
0.01%
-58.3%
Q4 2018$3,111,000
-7.7%
351,532
+33.4%
0.01%
+20.0%
Q2 2018$3,372,000
+1287.7%
263,475
+1729.7%
0.01%
+900.0%
Q1 2018$243,000
+7.5%
14,400
-49.1%
0.00%0.0%
Q4 2017$226,00028,2940.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders